| Ident. | Authors (with country if any) | Title |
|---|
| 000004 (2017) |
Susan H. Fox [Canada] ; Leonard Verhagen Metman [États-Unis] ; John G. Nutt [États-Unis] ; Matthew Brodsky [États-Unis] ; Stewart A. Factor [États-Unis] ; Anthony E. Lang [Canada] ; Laura E. Pope [États-Unis] ; Nadine Knowles [États-Unis] ; João Siffert [États-Unis] | Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease. |
| 000033 (2017) |
Lei Xing [Canada] ; Maddie J. Venables [Canada] ; Vance L. Trudeau [Canada] | Role of aromatase and radial glial cells in neurotoxin-induced dopamine neuron degeneration and regeneration. |
| 000045 (2017) |
Tea Lulic ; Jenin El-Sayes ; Hunter J. Fassett ; Aimee J. Nelson | Physical activity levels determine exercise-induced changes in brain excitability |
| 000055 (2017) |
Renato P. Munhoz [Canada] ; Delcio Bertucci Filho [Brésil] ; Hélio A G. Teive [Brésil] | Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype. |
| 000060 (2017) |
Karim Selfani [Canada] ; Valérie L. Soland ; Sylvain Chouinard ; Philippe Huot | Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole. |
| 000127 (2017) |
Chi Wang Ip [Allemagne] ; Laura-Christin Klaus [Allemagne] ; Akua A. Karikari [Allemagne] ; Naomi P. Visanji ; Jonathan M. Brotchie ; Anthony E. Lang ; Jens Volkmann [Allemagne] ; James B. Koprich | AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease |
| 000283 (2016) |
William J. Valente [États-Unis] ; Nolan G. Ericson [États-Unis] ; Alexandra S. Long [Canada] ; Paul A. White [Canada] ; Francesco Marchetti [Canada] ; Jason H. Bielas [États-Unis] | Mitochondrial DNA exhibits resistance to induced point and deletion mutations |
| 000338 (2016) |
Yue Shen [Canada] ; Fang Cheng [Finlande] ; Mehul Sharma [Canada] ; Yulia Merkulova [Canada] ; Sheetal A. Raithatha [Canada] ; Leigh G. Parkinson [Canada] ; Hongyan Zhao [Canada] ; Kathryn Westendorf [Canada] ; Lubos Bohunek [Canada] ; Tatjana Bozin [Canada] ; Ivy Hsu [Canada] ; Lisa S. Ang [Canada] ; Sarah J. Williams [Canada] ; R Chris Bleackley [Canada] ; John E. Eriksson [Finlande] ; Michael A. Seidman [Canada] ; Bruce M. Mcmanus [Canada] ; David J. Granville [Canada] | Granzyme B Deficiency Protects against Angiotensin II-Induced Cardiac Fibrosis. |
| 000346 (2016) |
Matthias Luz [Canada] ; Erich Mohr [Canada] ; H Christian Fibiger [Canada] | GDNF-induced cerebellar toxicity: A brief review. |
| 000370 (2016) |
W. Ruan [Canada] ; A. Srinivasan [Canada] ; S. Lin [Canada] ; K-I Kara [Canada] ; P A Barker [Canada] | Eiger-induced cell death relies on Rac1-dependent endocytosis |
| 000407 (2016) |
A Jon Stoessl [Canada] | Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias? |
| 000456 (2016) |
Claudia Trenkwalder [Allemagne] ; Daniela Berg [Allemagne] ; Olivier Rascol [France] ; Karla Eggert [Allemagne] ; Andres Ceballos-Baumann [Allemagne] ; Jean-Christophe Corvol [France] ; Alexander Storch [Allemagne] ; Lin Zhang [États-Unis] ; Jean-Philippe Azulay [France] ; Emmanuel Broussolle [France] ; Luc Defebvre [France] ; Christian Geny [France] ; Michal Gostkowski [États-Unis] ; Fabrizio Stocchi [Italie] ; Christine Tranchant [France] ; Pascal Derkinderen [France] ; Franck Durif [France] ; Alberto J. Espay [États-Unis] ; Andrew Feigin [États-Unis] ; Jean-Luc Houeto [France] ; Johannes Schwarz [Allemagne] ; Thérèse Di Paolo [Canada] ; Dominik Feuerbach [Suisse] ; Hans-Ulrich Hockey [Suisse] ; Judith Jaeger [États-Unis] ; Annamaria Jakab [Suisse] ; Donald Johns [États-Unis] ; Gurutz Linazasoro [Espagne] ; Paul Maruff [États-Unis] ; Izabela Rozenberg [Suisse] ; Judit Sovago [Suisse] ; Markus Weiss [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia. |
| 000469 (2015) |
Judith Antoine-Bertrand ; Philippe M. Duquette ; Ricardo Alchini ; Timothy E. Kennedy ; Alyson E. Fournier ; Nathalie Lamarche-Vane | p120RasGAP Protein Mediates Netrin-1 Protein-induced Cortical Axon Outgrowth and Guidance* |
| 000476 (2015) |
Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada] | Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking. |
| 000522 (2015) |
Tom M. Johnston [Canada] ; Susan H. Fox | Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates. |
| 000536 (2015) |
Philippe Huot [Canada] ; William D. Hutchison [Canada] | Serotonin/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia. |
| 000580 (2015) |
Laurent Grégoire [Canada] ; Tara Smith [Canada] ; Vijitha Senanayake [Canada] ; Asuka Mochizuki [Japon] ; Edith Miville-Godbout [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada] | Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys. |
| 000587 (2015) |
Abid Oueslati [Suisse, Canada] ; Blaise Lovisa [Suisse] ; John Perrin [Suisse] ; Georges Wagnières [Suisse] ; Hubert Van Den Bergh [Suisse] ; Yanik Tardy [Suisse] ; Hilal A. Lashuel [Suisse, Qatar] | Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease |
| 000592 (2015) |
Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni] | Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. |
| 000610 (2015) |
Jihye Park [Corée du Sud] ; Chae-Seok Lim [Corée du Sud] ; Hyunhyo Seo [Corée du Sud] ; Chung-Ah Park [Corée du Sud] ; Min Zhuo [Canada] ; Bong-Kiun Kaang [Corée du Sud] ; Kyungmin Lee [Corée du Sud] | Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) |
| 000630 (2015) |
Umar A. Shuaib ; Ali H. Rajput ; Christopher A. Robinson ; Alex Rajput | Neuroleptic‐induced Parkinsonism: Clinicopathological study |
| 000661 (2015) |
Chengfeng Xiao ; R. Meldrum Robertson | Locomotion Induced by Spatial Restriction in Adult Drosophila |
| 000663 (2015) |
Galit Saar [États-Unis] ; Ning Cheng [États-Unis, Canada] ; Leonardo Belluscio [États-Unis] ; Alan P. Koretsky [États-Unis] | Laminar Specific Detection of APP induced Neurodegeneration and Recovery using MEMRI in an Olfactory based Alzheimer’s Disease Mouse Model |
| 000695 (2015) |
Jonathan Degeer ; Andrew Kaplan ; Pierre Mattar ; Morgane Morabito ; Ursula Stochaj ; Timothy E. Kennedy ; Anne Debant ; Michel Cayouette ; Alyson E. Fournier ; Nathalie Lamarche-Vane | Hsc70 chaperone activity underlies Trio GEF function in axon growth and guidance induced by netrin-1 |
| 000707 (2015) |
Isabelle Beaulieu-Boire [Canada] ; Alfonso Fasano [Canada] | Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term. |
| 000721 (2015) |
Antonio Cerasa [Italie] ; Giacomo Koch [Italie] ; Alfonso Fasano [Canada] ; Francesca Morgante [Italie] | Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease |
| 000786 (2015) |
Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications. |
| 000794 (2015) |
Camila Catherine Aquino [Canada] ; Susan H. Fox | Clinical spectrum of levodopa-induced complications. |
| 000835 (2015) |
Jorge Gandía [Espagne] ; Xavier Morat [Espagne] ; Igor Stagljar [Canada] ; Víctor Fernández-Due As [Espagne] ; Francisco Ciruela [Belgique] | Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent. |
| 000840 (2015) |
Yuexin Shan ; Ali Akram ; Hajera Amatullah ; Dun Yuan Zhou ; Patricia L. Gali ; Tatiana Maron-Gutierrez ; Adrian González-L Pez ; Louis Zhou ; Patricia R. M. Rocco ; David Hwang ; Guillermo M. Albaiceta ; Jack J. Haitsma ; Claudia C. Dos Santos | ATF3 Protects Pulmonary Resident Cells from Acute and Ventilator-Induced Lung Injury by Preventing Nrf2 Degradation |
| 000845 (2015) |
Shirley Weiss ; Baruch Minke | A new genetic model for calcium induced autophagy and ER-stress in Drosophila photoreceptor cells |
| 000871 (2014) |
Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada] | Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. |
| 000920 (2014) |
Vincent A. Jourdain [Canada] ; Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Thérèse Di Paolo [Canada] | Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys. |
| 000972 (2014) |
Suk-Yu Yau [Canada] ; Joana Gil-Mohapel [Canada] ; Brian R. Christie [Canada] ; Kwok-Fai So [Hong Kong, République populaire de Chine] | Physical Exercise-Induced Adult Neurogenesis: A Good Strategy to Prevent Cognitive Decline in Neurodegenerative Diseases? |
| 000973 (2014) |
Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada] | Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates |
| 000988 (2014) |
Domenico L. Di Curzio [Canada] ; Emily Turner-Brannen [Canada] ; Marc R. Del Bigio [Canada] | Oral antioxidant therapy for juvenile rats with kaolin-induced hydrocephalus |
| 000A06 (2014) |
Antonio Cerasa [Italie] ; Alfonso Fasano [Canada] ; Francesca Morgante [Italie] ; Giacomo Koch [Italie] ; Aldo Quattrone [Italie] | Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology |
| 000A17 (2014) |
I A Prescott [Canada] ; L D Liu [Canada] ; J O Dostrovsky [Canada] ; M. Hodaie [Canada] ; A M Lozano [Canada] ; W D Hutchison [Canada] | Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia. |
| 000A44 (2014) |
John M. Woulfe [Canada] ; Madison T. Gray [Canada] ; Douglas A. Gray [Canada] ; David G. Munoz [Canada] ; Jaap M. Middeldorp [Pays-Bas] | Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease. |
| 000A67 (2014) |
James K. R. Stevenson [Canada] ; Chonho Lee [Singapour] ; Bu-Sung Lee [Singapour] ; Pouria Talebifard [Canada] ; Edna Ty [Canada] ; Kristina Aseeva [Canada] ; Meeko M. K. Oishi [États-Unis] ; Martin J. Mckeown [Canada] | Excessive Sensitivity to Uncertain Visual Input in L-DOPA-Induced Dyskinesias in Parkinson’s Disease: Further Implications for Cerebellar Involvement |
| 000A70 (2014) |
Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. Fox | Emerging drugs for levodopa-induced dyskinesia. |
| 000B60 (2014) |
Thérèse Di Paolo [Canada] ; Laurent Grégoire [Canada] ; Dominik Feuerbach [Canada] ; Walid Elbast [Canada] ; Markus Weiss [Canada] ; Baltazar Gomez-Mancilla [Canada] | AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys. |
| 000B90 (2014) |
YOUN JU LEE [Corée du Sud] ; So-Young Choi [Corée du Sud] ; Jae H. Yang [Corée du Sud] | NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells |
| 000C43 (2013) |
Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. Brotchie | The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease. |
| 000C50 (2013) |
James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie | The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques. |
| 000C54 (2013) |
Timothy K. Eitas ; Wei-Chun Chou ; Haitao Wen ; Denis Gris ; Gregory R. Robbins ; June Brickey ; Yoshitaka Oyama ; Jenny P.-Y. Ting [États-Unis] | The Nucleotide-binding Leucine-rich Repeat (NLR) Family Member NLRX1 Mediates Protection against Experimental Autoimmune Encephalomyelitis and Represses Macrophage/Microglia-induced Inflammation* |
| 000C81 (2013) |
Justine Renaud ; Julie Bournival ; Ximena Zottig ; Maria-Grazia Martinoli | Resveratrol Protects DAergic PC12 Cells from High Glucose-Induced Oxidative Stress and Apoptosis: Effect on p53 and GRP75 Localization |
| 000D31 (2013) |
Poonam Bhandari ; Moshi Song ; Yun Chen ; Yan Burelle ; Gerald W. Dorn | Mitochondrial Contagion Induced by Parkin Deficiency in Drosophila Hearts and Its Containment by Suppressing Mitofusin |
| 000D42 (2013) |
Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo | MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates. |
| 000D92 (2013) |
Jean-François Daneault [Canada] ; Benoit Carignan [Canada] ; Abbas F. Sadikot [Canada] ; Michel Panisset [Canada] ; Christian Duval [Canada] | Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? |
| 000E37 (2013) |
Golnasim Riahi ; Marc Morissette ; Pershia Samadi ; Martin Parent ; Thérèse Di Paolo | Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia. |
